Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricky W Johnstone

Showing results (11-20 of 188) with videos related to

Pageof 19
Sort By:
Nature Structural & Molecular Biology|September 25, 2019
Joseph F. Sambrook (1939-2019)Ashley Dunn, Ricky W Johnstone, Bruce Stillman
Epigenomics|December 1, 2011
Promises and challenges of anticancer drugs that target the epigenomeInge Verbrugge, Ricky W Johnstone, Michael Bots
Investigational New Drugs|December 17, 2010
Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effectMichael Dickinson, Ricky W Johnstone, H Miles Prince
Cell Cycle (Georgetown, Tex.)|May 22, 2004
Histone-deacetylase inhibitors for the treatment of cancerRalph K Lindemann, Brian Gabrielli, Ricky W Johnstone
Molecular Cancer Therapeutics|June 11, 2009
Epigenetics in cancer: targeting chromatin modificationsLeigh Ellis, Peter W Atadja, Ricky W Johnstone
Immunological Reviews|November 6, 2007
From cancer immunosurveillance to cancer immunotherapyJohn Stagg, Ricky W Johnstone, Mark J Smyth
Advances in Cancer Research|October 24, 2012
Intrinsic and extrinsic apoptotic pathway signaling as determinants of histone deacetylase inhibitor antitumor activityGeoffrey M Matthews, Andrea Newbold, Ricky W Johnstone
Cell|December 25, 2010
SnapShot: Extrinsic apoptosis pathwaysInge Verbrugge, Ricky W Johnstone, Mark J Smyth
Nature Reviews. Drug Discovery|September 7, 2006
Anticancer activities of histone deacetylase inhibitorsJessica E Bolden, Melissa J Peart, Ricky W Johnstone
Nature Reviews. Cancer|September 25, 2008
The TRAIL apoptotic pathway in cancer onset, progression and therapyRicky W Johnstone, Ailsa J Frew, Mark J Smyth
Pageof 19

Showing results (11-20 of 188) with videos related to

Sort By:
Pageof 19
Nature Structural & Molecular Biology|September 25, 2019
Joseph F. Sambrook (1939-2019)Ashley Dunn, Ricky W Johnstone, Bruce Stillman
Epigenomics|December 1, 2011
Promises and challenges of anticancer drugs that target the epigenomeInge Verbrugge, Ricky W Johnstone, Michael Bots
Investigational New Drugs|December 17, 2010
Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effectMichael Dickinson, Ricky W Johnstone, H Miles Prince
Cell Cycle (Georgetown, Tex.)|May 22, 2004
Histone-deacetylase inhibitors for the treatment of cancerRalph K Lindemann, Brian Gabrielli, Ricky W Johnstone
Molecular Cancer Therapeutics|June 11, 2009
Epigenetics in cancer: targeting chromatin modificationsLeigh Ellis, Peter W Atadja, Ricky W Johnstone
Immunological Reviews|November 6, 2007
From cancer immunosurveillance to cancer immunotherapyJohn Stagg, Ricky W Johnstone, Mark J Smyth
Advances in Cancer Research|October 24, 2012
Intrinsic and extrinsic apoptotic pathway signaling as determinants of histone deacetylase inhibitor antitumor activityGeoffrey M Matthews, Andrea Newbold, Ricky W Johnstone
Cell|December 25, 2010
SnapShot: Extrinsic apoptosis pathwaysInge Verbrugge, Ricky W Johnstone, Mark J Smyth
Nature Reviews. Drug Discovery|September 7, 2006
Anticancer activities of histone deacetylase inhibitorsJessica E Bolden, Melissa J Peart, Ricky W Johnstone
Nature Reviews. Cancer|September 25, 2008
The TRAIL apoptotic pathway in cancer onset, progression and therapyRicky W Johnstone, Ailsa J Frew, Mark J Smyth
Pageof 19